Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,956 | 23,650 | 36,893 | 13,087 | 14,867 |
| Marketable Securities | 23,524 | 32,546 | 17,434 | 27,079 | 22,914 |
| Receivables | 9,564 | 8,768 | 5,968 | 2,234 | 7,384 |
| Inventories | 655 | 500 | 2,232 | 1,949 | 1,949 |
| Other current assets | 82 | 85 | 98 | 89 | 90 |
| TOTAL | $113,502 | $66,987 | $64,632 | $46,112 | $50,425 |
| Non-Current Assets | |||||
| PPE Net | 9,753 | 9,922 | 10,095 | 10,112 | 8,362 |
| Investments And Advances | 3,803 | 8,926 | 14,371 | 24,154 | 41,134 |
| Other Non-Current Assets | 2,455 | 4,012 | 2,404 | 1,839 | 2,960 |
| TOTAL | $16,011 | $22,860 | $26,870 | $36,105 | $52,456 |
| Total Assets | $129,513 | $89,847 | $91,502 | $82,217 | $102,881 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,276 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 15,724 | 13,259 | 10,323 | 14,254 | 15,665 |
| Accrued Expenses | 11,335 | 10,836 | 10,782 | 11,783 | 17,328 |
| TOTAL | $58,557 | $54,360 | $51,520 | $56,194 | $63,070 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,611 | 22,777 | 22,665 | N/A | N/A |
| Deferred Revenues | 1,869 | 2,022 | 2,282 | 2,134 | 2,163 |
| Other Non-Current Liabilities | 0 | 0 | 1,904 | 974 | 0 |
| TOTAL | $32,426 | $33,909 | $35,989 | $12,636 | $12,013 |
| Total Liabilities | $90,983 | $88,269 | $87,509 | $68,830 | $75,083 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,421 | 73,955 | 73,758 | 73,701 | 73,693 |
| Common Shares | 804 | 738 | 738 | 737 | 737 |
| Retained earnings | -580,280 | -566,061 | -561,558 | -550,030 | -533,749 |
| Other shareholders' equity | -3 | -12 | 22 | 46 | 48 |
| TOTAL | $38,530 | $1,578 | $3,993 | $13,387 | $27,798 |
| Total Liabilities And Equity | $129,513 | $89,847 | $91,502 | $82,217 | $102,881 |